The main benefit of laparoscopic staging (LLU) of (distal) biliopancreatic malignancy is the detection of small superficial metastases at the liver surface and peritoneum and local tumor ingrowth. The different aspects of laparoscopic staging have been described extensively in the literature and the benefit is generally expressed in terms of prevention of laparotomy. The impact of this final staging procedure on outcome for the patient in terms of the efficacy of the subsequent non-surgical palliative treatment have been analysed scarsly. In this review the results of laparoscopic staging of bilio-pancreatic tumors concerning the detection of metastases and tumor ingrowth as well as the results of long term follow up after subsequent non-surgical treatment and the preferred palliative treatment after laparoscopic staging are discussed.
Introduction
The diagnosis of biliopancreatic malignancy can already be made in around 80-90% of the patients on the basis of the clinical presentation. Consequently imaging pocedures are mainly focused to confirm the diagnosis and to identify patients who are candidate for curative resection. Despite improvement of conventional (radiological) staging metastases or locally advanced disease has been found during surgery in 10 to 40% of the patients. Therefore diagnostic laparoscopy combined with laparoscopic ultrasonography was introduced to improve assessment of tumor stage and to prevent unnecessary explorations [1] [2] [3] . The main additional benefit of the laparoscopy is the detection of small superficial metastases at the liver surface and peritoneum [1] [2] [3] . These metastases can easily be missed with ultrasound and CT-scan and are therefore first encountered during laparotomy [3, 4, 5] . Laparoscopic ultrasonography is added to the standard laparoscopy in an attempt to detect small intrahepatic metastases and assessment of local tumor ingrowth and enlarged suspicious lymph nodes [6] [7] [8] . The different aspects of laparoscopic staging have been described extensively in the literature for pancreatic tumors and the benefit is expressed mainly in terms of prevention of laparotomy. The impact of this final staging procedure on outcome for the patient in terms of the efficacy of the subsequent non-surgical palliative treatment have been analysed scarsely.
In this review the results of laparoscopic staging of biliopancreatic tumors concerning the detection of metastases and tumor ingrowth will be summarized. The additional value of laparoscopic ultrasonography and peritoneal lavage during laparoscopy will be evaluated. Furthermore results of long term follow up after subsequent non-surgical treatment and the preferred palliative treatment after laparoscopic staging will be discussed.
Indications for laparoscopic staging
Diagnostic laparoscopy is generally indicated for patients with biliopancreatic carcinoma who are candidates for resection of the tumor and thus in patients without signs of metastatic disease or tumor ingrowth. A second prerequisite for performing laparoscopic staging is the acceptance of a non-operative or laparoscopic palliative treatment. If surgical palliative treatment is the first choice diagnostic work up should be limited. Another indication could be to perform laparoscopy for confirmation of locally advanced disease versus metastatic disease if neo-adjuvant treatment options as radiotherapy or chemotherapy are considered. Contra-indications are signs of (duodenal) obstruction because these patients need a gastroenterostomy anyhow and laparoscopy related contra-indications as extended abdominal adhesions or the presence of a large diaphragmatic hernia. A previous laparotomy is no absolute contra-indication but an open approach for introduction of the first trocar is recommended [9] .
Diagnostic laparoscopy and laparoscopic ultrasonography
Diagnostic laparoscopy is performed under general anesthesia and as a separate procedure in our institution [7, 8] . The pneumoperitoneum is installed with CO 2 and 3 trocars are inserted. Inspection of the abdominal cavity is performed to identify small peritoneal metastases. The inspection includes the visceral peritoneum in particular the hepatoduodenal ligament, the Treitz ligament, mesocolon and radix mesenterii. It is followed by peritoneal lavage with 500 ml normal saline which is examined for malignant cells after staining with Papanicolaou and Giemsa [10] . Thereafter laparoscopic ultrasono-graphy is performed with a 7.5 mHz liniar array US-probe (Aloka, Tokyo, Japan). The ultrasound is performed by the surgeon but a radiologist is always present in the operating room for interpretation of the ultrasound findings. Laparoscopic ultrasound is performed to identify small intrahepatic metastases and to analyse ingrowth of the tumor in the portal and mesenteric vessels [11] . Finally biopsies of suspected lesions are performed at the end of the procedure with a biopsy forceps or Trucut needle (Travenol Laboratories, Denfield, Illinois, USA). The primary tumor should not be biopsied if radical surgery is still considered. 
Complications of diagnostic laparoscopy
The morbidity and mortality after laparoscopic staging are reported to be low, although most studies were retrospective and this could lead to an underestination of the true incidence of complications. Major complications, including bleeding from biopsy sites, bowel perforations, peritonitis and anaphylactic shock are reported between 0.3-2.3% [1, 2, 5, 6, 8] . Minor complications defined as complications without surgical reintervention are reported between 1-9 %.In a prospective analysis of 400 patients who underwent diagnostic laparoscopy at the AMC major and minor complications occured respectively in 0.75% and 3% as summarized in table I [12] . Port site metastases defined as tumor recurrence in the trocar scars are reported between 0-3% in the literature. The incidence in our series of more than 500 patients was 2% as reported previously [13] . Direct tumor spread by laparoscopic instruments and indirect tumor spread due to the high-pressure pneumoperitoneum or by insufflation of gas have been studied but the exact mechanism for this phenomenon is not yet understood [13, 14, 15] .
Detection of metastases
Detection of metastases is the most important aspect of laparoscopic staging because tumor seeding is a definite predictor of irresectability. For patients with tumors in the pancreatic head region and pancreatic body/tail metastases were found by diag-nostic laparoscopy between 20-82% (table 2) . Patient selection and preoperative staging procedures explain the variation in detection rate of metastases. In an earlier study from our institution the benefit (prevention of laparotomy) was 29% but it decreased to 15% probably mainly due to the introduction of the spiral CT-scan as routine investigation in all patients before diagnostic laparoscopy is performed [7, 8, 12] . Warshaw described also a decrease in the prevalence of metastases in two subsequent studies from 19% to 15% [2, 5] . It is also suggested that this could be due to changes in referral pattern. Patients could be referred at an earlier phase of the disease. Remarkably the resection rate did not increase in the total group of patients referred at the AMC.
Detection of tumor ingrowth
Tumor ingrowth is another important cause of irresectability which can be detected incidentally during laparoscopy at the mesocolon and Treitz ligament. However vascular involvement of the tumor can most commonly be visualized by laparoscopic ultrasonography. It is most frequently found in the portal venous system, the mesenteric vein and artery or hepatic artery. In the literature laparoscopic ultrasonography could detect tumor ingrowth between 9 and 25% as summarized in table 3. Furthermore tumor ingrowth in these vascular structures was often already detected by transabdominal ultrasound combined with doppler or spiral CT-scan and it was not a new finding [11] . Therefore the additional value of ultrasound is less than reported from most studies. In our series of more than 200 patients with a periampullary malignancy tumor ingrowth was found in 49/223 (22%). A number of these patients had already metastases or tumor ingrowth detected or suspected by previous investigation. It was a new finding in only 10/223 (5%) and unfortunately this could not be proven by pathology in most of these patients.
Proximal bile duct tumors
Patients with a proximal bile duct tumor (Klatskin tumor) have a higher benefit of laparoscopic staging. In our series of 47 patients metastases were found in 19 (40%). The sensitivity for detection of metastases was 0.95 and the negative predictive value 0.96 [12] . Local tumor ingrowth was detected by laparoscopic ultrasound in another 3 patients 11% but this could not be proven by pathology and these patients underwent exploration. The sensitivity for detection of tumor ingrowth for proximal bile duct carcinoma was low 0.30.
Peritoneal lavage
Peritoneal lavage fluid during laparoscopy with positive cytology has been reported between 3 and 29% (table 4) . Warshaw reported 29% but in his series many patients with advanced disease were included and intra-abdominal spread of the disease is frequently associated with positive cytology of the lavage fluid [5, 25] . In our series peritoneal lavage was less helpful [10] . This is probably partly due to patient selection but also related with the conventional staining methods (Giemsa and Papanicolaou) used. Most patients with positive lavage (5/7) had li ver metastases already shown by laparoscopy. The results of cytology showed a significant effect on survival. Patients with positive lavage had a shorter survival (3 months) compared with patients with negative lavage 13 months. In patients with a proximal bile duct carcinoma 15% showed to have positive lavage but again most patients 9/11 had metastases already shown by laparoscopy [10] . There was also a correlation with survival. Results of lavage can be improved by using new immunocytological staging methods as shown recently [26, 27] . Micrometastases were found in 30% of the patients and the use of these techniques could change the additional value of lavage [27].
Long term efficacy
As mentioned it has been shown that laparoscopic staging prevents explorative laparotomies between 20-82%. However only the early advantages of laparoscopic staging (prevention initial laparotomy) have been evaluated in most studies. The long term efficacy, defined as early minus later laparotomies (during follow up), has only been studied recently.
In a series of our institution secondary laparotomies had to be performed in 29% of the patients with periampullary tumors and 22% of the patients with proximal bile duct tumors who underwent non surgical palliative treatment after diagnostic laparoscopy [20] . Most of these late laparotomies were necessary because of duodenal obstruction and patients underwent a surgical bypass (gastrojejunostomy).The initial benefit of laparoscopy in periampullary tumors declined from 15% to 11%. Laparoscopic staging should only be accepted if non surgical palliative treatment is sufficient. Because 30% of the patients underwent a late laparotomy for duodenal obstruction and a number of patients required one or more stent exchanges during follow up there is still doubt about the outcome of treatment after laparoscopy. Therefore recently a multicenter study was performed to analyse the effect of laparoscopy and secondly the outcome of treatment of patients staged as irresectable after laparoscopy. These patients were randomized for an endoscopic treatment versus a surgical bypass. This study showed that laparotomy could be avoided in only 13%. These patients were randomized for endoscopic treatment with a wallstent versus a double surgical bypass. The overall hospital stay (during the remaining life) was not different for both patient groups. A longer hospital free survival was found in patients who underwent a bypass. The benefit of diagnostic laparoscopy in patients with proximal bile duct tumors is much hi-gher and around 40% [7, 8, 11, 12] . The additional value of peritoneal lavage is limited [5, 10, 18, 25] . Positive lavage has been reported between 3 and 24% but positive lavage strongly correlated with the presence of metastases, already shown by other investigations. It can be concluded that cytology of peritoneal lavage with conventional staining (Giemsa and Papanicolaou) should not longer be performed [20] . New techniques (immunocytochemistry) have been shown to be more sensitive for the detection of tumor cells and positive lavage results have been reported in 51 % of the patients with colorectal cancer [27] . It is still doubtful if specific monoclonal antibodies will become available for biliopancreatic tumors. If these new techniques are proven to be adequate the role of peritoneal lavage should be reconsidered. Due to the relative high incidence (30%) of patients with a pancreatic carcinoma who will undergo a surgical palliative procedure during follow up the efficacy of diagnostic laparoscopy was disappointing and remained doubtful in this (selected)group of patients [20] . Besides the patients who develop duodenal obstruction and require a gastric bypass operation a number of patients need also one or more exchanges of the endoprosthesis. An alternative for non operative palliation is a double bypass and this was recently assessed in a prospective randomized trial. This study demonstrated that the surgical bypass procedure should be preferred in patients with periampullary carcinoma. Therefore laparoscopy should not be performed in this group of patients anymore.
